Mon.Jun 17, 2024

article thumbnail

The Rise of Reverse Plagiarism in Research

Plagiarism Today

Increasingly, researchers are finding that they're victims of reverse plagiarism. Where their name is added to works didn't contribute to. The post The Rise of Reverse Plagiarism in Research appeared first on Plagiarism Today.

article thumbnail

25 Branding Tips

Erik K Pelton

The following is an edited transcript of my video 25 Branding Tips. As we celebrate our 25th year, I am excited to share 25 branding tips with you: Choose a creative name – it’s the foundation you begin with to build a bold brand. Begin with a clearance search to make sure that any new name is available. Register your trademark. Be sure to file early to help build more protection.

Branding 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

3 Count: Badder Boys

Plagiarism Today

Columbia Pictures settles with Bad Boys author, Hollywood trainer loses bid to copyright method and Feid accused of unlicensed samples. The post 3 Count: Badder Boys appeared first on Plagiarism Today.

article thumbnail

A Trademark Dispute Plays Out Before the NAD

JD Supra Law

Planting Hope had a registration for the RIGHTRICE trademark, but that registration was canceled in January 2024 by the U.S. Patent & Trademark Office (“USPTO”) in a default judgment proceeding after Planting Hope failed to respond to a petition for cancellation. Planting Hope filed a motion to set aside the default judgment, but kept using the registered trademark symbol while that proceeding was pending.

Trademark 115
article thumbnail

Software Composition Analysis: The New Armor for Your Cybersecurity

Speaker: Blackberry, OSS Consultants, & Revenera

Software is complex, which makes threats to the software supply chain more real every day. 64% of organizations have been impacted by a software supply chain attack and 60% of data breaches are due to unpatched software vulnerabilities. In the U.S. alone, cyber losses totaled $10.3 billion in 2022. All of these stats beg the question, “Do you know what’s in your software?

article thumbnail

Sony DMCA Notice Nukes 200 Aniyomi Extensions as Tachiyomi Fork Feels Heat

TorrentFreak

Whether it’s Hollywood movies, TV shows, music, or static publications such as books and magazines, millions of people are now very comfortable consuming content via apps. In many cases, third-party apps simply act as a hub, utilizing content made available by other services. When developers dedicate themselves to a particular content niche, mobile apps can become very popular indeed, especially so when they outgun legitimate apps produced by rightsholders themselves.

Copyright 117
article thumbnail

Tesla Slaps Supplier With $1B EV Battery Trade Secrets Suit

IP Law 360

Tesla accused one of its suppliers of corporate espionage in a $1 billion California federal lawsuit, saying that Matthews International has even tried to claim it invented the stolen trade secrets for manufacturing electric vehicle batteries by incorporating the confidential information into patent filings.

More Trending

article thumbnail

Protecting Confidential Intellectual Property in the Wake of the FTC’s “Final Rule” Against Non-Competition Provisions

JD Supra Law

As the Federal Trade Commission (FTC) implements “the final rule” banning non-competes, businesses with sensitive intellectual property (IP) must look to alternative measures to safeguard it. Despite apprehension about the ability to protect valuable IP without restrictive non-competes, in “the final rule” (16 CFR Parts 910 and 912), the FTC aims to increase future reliance on non-disclosure agreements (NDAs).

article thumbnail

Are You Better Off Today Than You Were Five Years Ago? Selected comments on the MLC Redesignation: American Association of Independent Music (A2IM)

The Trichordist

A2IM raises important issues about conditioning redesignation on improvements in the shortcomings of the MLC's matching systems and black box procedures.

Music 90
article thumbnail

USPTO Seeks Public Comment on the Impact of Artificial Intelligence on Patentability

JD Supra Law

The relentless march of technological progress presents a unique challenge for the intellectual property (IP) landscape. Earlier this year, the United States Patent and Trademark Office (USPTO) issued a Request for Comments (RFC) on inventorship guidance for AI-assisted inventions. By: Sterne, Kessler, Goldstein & Fox P.L.L.C.

article thumbnail

Color, Sneakers, Parody, AI and the ‘F’ Word: It’s Already Been Quite a Year for Trademarks

IP Watchdog

It has already been quite a year in the world of U.S. trademark practice. If you manufacture a highly colorful product, are the owner of a well-known trademark, are an AI start-up company or are testing the waters as to whether a certain, unsavory word is protectable, pay attention to developments that have happened in just the first half of 2024.

article thumbnail

IPO Diversity in Innovation Toolkit

Women and diverse employees have the technical skill and knowledge, yet their contributions are not patented at the same rate as those of their male counterparts.This toolkit can help organizations move the needle on achieving gender parity in innovation.

article thumbnail

CVS Pharmacy Inc. v. Forest Laboratories Inc. (2d Cir. 2024)

JD Supra Law

In a decision characterized (somewhat remarkably) by the Circuit Court as being one of first impression, the Second Circuit affirmed dismissal with prejudice of an antitrust allegation by a class of plaintiffs* against Forest Laboratories and several generic drug companies** for settlement agreements in ANDA litigation, in CVS Pharmacy Inc. v. Forest Laboratories Inc.

article thumbnail

Top Patent Eligibility Rulings In The Decade Since Alice

IP Law 360

The U.S. Supreme Court's Alice v. CLS Bank decision 10 years ago this week led to scores of inventions being found ineligible for patenting, and rulings since then have fleshed out the law on the contentious topic. Here's a look at the most notable patent eligibility decisions after Alice.

Patent 64
article thumbnail

International News: Spotlight on Innovation - Issue 60

JD Supra Law

Innovation fuels business growth and ushers in success, yet it brings its own set of challenges. In our latest issue, we explore innovative products and processes including: - The EU’s new Unified Patent Court simplifying patent protection with a single application process, a significant leap from the previous system’s complexity. - Custom new financial instruments, like junior capital and revenue-based financing, catering to the unique needs of startups and expanding businesses. - The.

article thumbnail

Trade Secret Misappropriation Preliminary Injunction Reversed

Patently-O

By Dennis Crouch The Federal Circuit has reversed a preliminary injunction order in a trade secret misappropriation case, finding that the district court abused its discretion by failing to properly evaluate the likelihood of success on the merits and the balance of harms. Insulet Corp. v. EOFlow, Co. , No. 2024-1137 (Fed. Cir. June 17, 2024). The appellate court held that the district court’s analysis was deficient in several key respects, including not addressing the statute of limitatio

article thumbnail

Texas Patent Litigation Monthly Wrap-Up: May 2024

JD Supra Law

The Texas Patent Litigation Monthly Wrap-Up for May 2024 covers three decisions addressing amendments to infringement contentions, stays while similar actions proceed, and personal jurisdiction over holding companies.

article thumbnail

Intellectual Property Rights and Pharmaceutical Sector: Analyzing the Dynamic Relationship in India’s Drug Market

IIPRD

INTRODUCTION: The Indian pharmaceutical companies are in a unique position where they are balancing the role of being a generic Global drug supplier and also ensuring that their products are accessible and affordable to everyone. However, balancing through such many factors especially to maintain the interplay between the regulatory policies and the pricing strategies is crucial.

article thumbnail

5 Key Takeaways | Key Takeaways from the ITC Litigation and Enforcement Conference

JD Supra Law

The ITC Keeps Changing in 2024. Aarti Shah of Kilpatrick co-chaired American Conference Institute’s ITC Litigation and Enforcement Conference in May, where many of these changes and trends were discussed.

article thumbnail

Male Enhancement Pills Infringe RAW Trademark, Co. Says

IP Law 360

HBI International, the American distributor of the RAW line of smoking products, has filed a lawsuit in Georgia federal court alleging Mash Enterprise LLC used "identical copies" of its trademarks, trade dress and copyrighted packaging to sell male enhancement pills and beverages.

article thumbnail

Spotlight On: Biosimilar Litigations - June 2024

JD Supra Law

Biosimilar Litigations include litigations relating to biosimilar/follow-on products of CDER-listed reference products. Litigations between biosimilar applicants/manufacturers and reference product sponsors as well as litigations between two biosimilar applicants/manufacturers are included. Litigations relating to disputes between two reference product sponsors, or non-practicing entities/universities and reference product sponsors are not included.

article thumbnail

'Anderson Method' Copyright Claim Gets Cut Ahead Of Trial

IP Law 360

A California federal judge has handed Tracy Anderson's former employee Megan Roup a summary judgment win on the celebrity fitness trainer's copyright claim accusing Roup of ripping off her "Tracy Anderson Method" exercise routines, but concluded a jury should decide Anderson's sole remaining breach-of-contract claim in an upcoming November trial.

article thumbnail

Spotlight On: Rituxan® (rituximab) / Truxima® (rituximab-abbs) / Ruxience® (rituximab-pvvr) / Riabni™ (rituximab-arrx) - June 2024

JD Supra Law

*Rituximab Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple litigations/IPRs are counted more than once. Within each litigation a claim is counted only once. Within each IPR, claims are counted only once, whether they are challenged under § 102, § 103, or both.

article thumbnail

A Look at Key USPTO Director Review Decisions and their Significance

IP Watchdog

Prior to the Supreme Court’s 2021 decision in United States v. Arthrex, Inc., while there were some mechanisms for review of decisions by Patent Trial and Appeal Board (PTAB) panels, Director Review (DR) as a standalone review mechanism was essentially non-existent. After Arthrex, however, that changed—with the U.S. Patent and Trademark Office (USPTO) setting forth an interim DR process, followed by a revised DR process, and now formal rulemaking in April 2024.

article thumbnail

Spotlight On: Lantus® / Lantus® SoloSTAR® (insulin glargine recombinant) / Basaglar® (insulin glargine) / Semglee® (insulin glargine) / Rezvoglar™ (insulin glargine-aglr) - June 2024

JD Supra Law

*Insulin Glargine Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple litigations/IPRs are counted more than once. Within each litigation a claim is counted only once. Within each IPR, claims are counted only once, whether they are challenged under § 102, § 103, or both.

article thumbnail

NJ Firm Defends Lien On Ex-Client's Patents After Unpaid Bills

IP Law 360

A major New Jersey law firm said it has a "common law" right to place a lien on its former client's patents without telling it, after the "failed" biopharmaceutical startup fired the firm and stopped paying its outstanding legal bills.

Patent 52
article thumbnail

Spotlight On: Humira® (adalimumab) / Amjevita™ (adalimumab-atto) / Cyltezo® (adalimumab-adbm) / Hyrimoz™ (adalimumab-adaz) / Hadlima™ (adalimumab-bwwd) / Abrilada™ (adalimumab-afzb) / Hulio® (adalimumab-fkjp) / Yusimry™ (adalimumab-aqvh) / Idacio® (adalimumab-aacf) / Yuflyma® (adalimumab-aaty) / Simlandi® (adalimumab-ryvk) - June 2024

JD Supra Law

*Adalimumab Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple litigations/IPRs are counted more than once. Within each litigation a claim is counted only once. Within each IPR, claims are counted only once, whether they are challenged under § 102, § 103, or both.

article thumbnail

Microsoft Renews Sanctions Bid Against Texas IP Law Firm

IP Law 360

Microsoft asked a Texas federal court Friday to order Ramey LLP to pay its $100,000 attorneys' fees tab for "vexatiously" pursuing infringement litigation against it, even when the patent plaintiffs firm's now-former client CTD Networks LLC called for it to end.

Law 52
article thumbnail

Preliminary Injunction Issued Against Samsung Bioepis in Aflibercept BPCIA Litigation

JD Supra Law

In a sealed order that issued last week, the Court has granted a preliminary injunction against Samsung Bioepis in the aflibercept BPCIA litigation brought by Regeneron.

article thumbnail

Startup Wants to Add More Than $200M To Boeing IP Verdict

IP Law 360

Zunum Aero Inc. is urging a Washington federal judge to significantly boost a $72 million jury verdict against the Boeing Co. for misappropriating the electric jet startup's trade secrets, including adding $162.5 million in exemplary damages and nearly $52 million in legal costs and interest.

IP 52
article thumbnail

Shifting Burden Dooms Patent Owner

JD Supra Law

In a Final Written Decision, the PTAB declared claims of a patent unpatentable after finding the patent was not entitled to the earlier priority date of the anticipatory reference in Platinum Optics Technology, Inc. v. Viavi Solutions Inc., IPR2022-01489 (Apr. 11, 2024). Notably, the PTAB shifted the burden of production to Patent Owner to show the ’794 patent was entitled to the filing date of the reference (the “Hendrix” reference) and Patent Owner ultimately failed to show the claims of the.

Patent 61
article thumbnail

Judge Cements Decision Clearing Cisco From $2.75B Ruling

IP Law 360

There will be not be a third trial for a cybersecurity startup that has seen its multibillion-dollar patent win turn into nothing at all, a Virginia federal judge has decided, after a second trial found that Cisco wasn't actually infringing its patents.

Patent 52
article thumbnail

Government IP Funding Programs Across Canada

Canadian Intellectual Property Blog

Securing intellectual property (IP) rights is a critical step for businesses, particularly for start-ups and small or medium-sized enterprises (SMEs), who want to gain a competitive advantage in the marketplace. To assist in funding IP-related costs, various government funding programs have been developed across Canada to help companies secure IP rights.

article thumbnail

Repeat Violations Land Ore. Forwarder Export Denial Order

IP Law 360

An Oregon-based package forwarder has lost export privileges just days before clearing a three-year probationary period for alleged unlicensed rifle scope exports, after an audit revealed 176 new violations, the U.S. Department of Commerce announced Monday.

52
article thumbnail

Comparative Analysis: Madrid Protocol vs. Direct National Filing in India

Intepat

Introduction Trademarks are the identifiers that enable businesses to establish a strong footing in the global marketplace. Although there are many well-known marks in the industry, registering marks is a vital process for businesses to safeguard their brand identity and intellectual property and to obtain exclusive rights over them. Trademark law underwent substantial changes, both multilaterally and regionally.

article thumbnail

Boeing, Virgin Can't Agree To Injunction's Scope In IP Row

IP Law 360

Boeing and Virgin Galactic have clashed over whether Virgin can share information with outside contractors gleaned as part of a failed aircraft development contract, as Boeing's suit accusing Virgin of breaching the deal and misappropriating trade secrets moves forward in Virginia federal court.

article thumbnail

BlawgReview jumps the shark

Likelihood of Confusion

Originally posted 2006-03-13 11:00:34. Republished by Blog Post PromoterWhat should be the last edition is up here. Stick a fork in it; it’s done. UPDATE: Colin Samuels seems to agree; the redoubtable (and eminently dignified) blokes at Law Review Central vow revenge, or something. (What a bunch of clowns.) The post BlawgReview jumps the shark appeared first on LIKELIHOOD OF CONFUSION™.

Editing 52